VivoSim Labs, Inc.
VivoSim Labs, Inc. (VIVS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
vivs · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for VivoSim Labs, Inc. (VIVS) measures how much investors pay for each dollar of the company's trailing earnings. VIVS's current PE ratio of N/A is calculated by dividing its stock price of $1.19 by its TTM earnings per share of -$0.84.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2011 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
VivoSim Labs, Inc.You VIVS | $3M | N/A | — | -$0.84 |
 Cyclerion Therapeutics, Inc. CYCN | $13M | N/A | — | -$1.09 |
 Impact BioMedical Inc. IBO | $7M | N/A | — | -$0.38 |
 Pasithea Therapeutics Corp. KTTA | $4M | N/A | — | -$2.91 |
 NovaBay Pharmaceuticals, Inc. NBY | $39M | N/A | — | -$3.80 |
 Polyrizon Ltd. PLRZ | $14M | N/A | — | -$2.07 |
 PharmaCyte Biotech, Inc. PMCB | $5M | 0.30x | — | $4.18 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | — | $-1.70 | — | |
2024-03-31 FY2024 | — | $-19.25 | — | |
2023-03-31 FY2023 | — | $-23.77 | — | |
2022-03-31 FY2022 | — | $-15.78 | — | |
2021-03-31 FY2021 | — | $-29.25 | — | |
2020-03-31 FY2020 | — | $-34.66 | — | |
2019-03-31 FY2019 | — | $-55.40 | — | |
2018-03-31 FY2018 | — | $-77.89 | — | |
2017-03-31 FY2017 | — | $-94.38 | — | |
2016-03-31 FY2016 | — | $-102.80 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for VivoSim Labs, Inc. (VIVS) measures how much investors pay for each dollar of the company's trailing earnings. VIVS's current PE ratio of N/A is calculated by dividing its stock price of $1.19 by its TTM earnings per share of -$0.84.
Frequently asked questions
VIVS pe ratio · 6 questionsVIVS's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.19 and TTM EPS of -$0.84. Data sourced from Financial Modeling Prep via VIVS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · VivoSim Labs, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09